Provided by Tiger Trade Technology Pte. Ltd.

Summit Therapeutics PLC

17.00
-0.5400-3.08%
Pre-market: 16.90-0.1000-0.59%04:24 EDT
Volume:4.22M
Turnover:72.00M
Market Cap:13.56B
PE:-15.21
High:17.62
Open:17.30
Low:16.80
Close:17.54
52wk High:29.23
52wk Low:12.07
Shares:797.75M
Float Shares:152.34M
Volume Ratio:0.56
T/O Rate:2.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1177
EPS(LYR):-1.4439
ROE:-192.50%
ROA:-101.61%
PB:21.53
PE(LYR):-11.77

Loading ...

Summit Therapeutics Falls After Share Sale Plans, Q2 Report

Reuters
·
Jul 24

Piper Sandler Keeps Their Hold Rating on Summit Therapeutics (SMMT)

TIPRANKS
·
Jul 24

Stock Track | Summit Therapeutics PLC Plunges 5.54% Intraday on Widening Non-GAAP Loss and $380 Million Stock Offering Plan

Stock Track
·
Jul 24

Summit Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 24

Summit Therapeutics Launches At-the-market Equity Program for up to $380 Million

Reuters
·
Jul 24

Stock Track | Summit Therapeutics Plunges 6% After-Hours as Non-GAAP Loss Widens on Surging Ivonescimab Development Costs

Stock Track
·
Jul 24

Summit Therapeutics says will need to raise additional capital

TIPRANKS
·
Jul 24

Summit Therapeutics - to Offer and Sell Common Stock up to $380 Mln Aggregate Through Sales Agent - SEC Filing

THOMSON REUTERS
·
Jul 24

Summit Therapeutics Q2 FY26 Net Loss Narrows to $215.7 Million

Reuters
·
Jul 24

Summit Therapeutics Q2 Net Income USD -215.7 Million

Reuters
·
Jul 24

Summit Therapeutics Q2 EPS USD -0.28

THOMSON REUTERS
·
Jul 24

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2026

THOMSON REUTERS
·
Jul 24

Analysts Have Conflicting Sentiments on These Healthcare Companies: Summit Therapeutics (SMMT), Molina Healthcare (MOH) and Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 23

European Car Market Stages Robust Recovery with Strongest Monthly Sales Gain in Nearly Three Years, Electric Vehicles Provide Critical Boost

Stock News
·
Jul 23

UK’s EV battery sector moves to industrial scale, but can it build a midstream?: Battery Cells & Systems Expo

Fastmarkets
·
Jul 23

Arcus Biosciences, Summit Therapeutics Team up to Test Casdatifan-ivonescimab Combo in Kidney Cancer

Reuters
·
Jul 23

Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer

THOMSON REUTERS
·
Jul 23

Summit Gains on Updated Trial Data for Experimental Lung Cancer Drug

Reuters
·
Jul 22

Summit Therapeutics Announces Availability of Ivonescimab Harmoni Trial Update Press Release

Reuters
·
Jul 22

Summit Therapeutics - FDA Accepts Bla for Ivonescimab; Pdufa Date November 14, 2026

THOMSON REUTERS
·
Jul 22